A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

GRAND JUNCTION, Colo. (KJCT) - Mesa County Public Health hosted a measles-mumps-rubella, or MMR, vaccine clinic on April 26. Locals had the opportunity to get the vaccine, check up on their ...

The two-dose measles mumps and rubella (MMR) vaccine is widely available, with the first dose recommended for children between the ages of 12 and 15 months and the second dose recommended between ...

Two doses of the measles, mumps and rubella (MMR) or measles, mumps, rubella and varicella vaccine (MMRV) offer almost 100 per cent effectiveness in the long term. Even so, immunologist Dawn ...

The two exceptions were a pair of 1-year-old children in Ingham County, both of whom received at least one dose prior to infection, which follows the recommended childhood vaccine schedule.

CHATHAM, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...

We cannot allow vaccine-preventable conditions, such as measles and whooping cough, to become regularly occurring outbreaks here in the U.S. again, causing needless suffering and death.

Mounting evidence suggests that vaccination against the varicella zoster virus—which causes chickenpox in children and triggers shingles in adults—also protects the brain. Several recent ...

WASHINGTON (AP) — Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.

Novavax says its COVID-19 vaccine BLA is approvable and awaits FDA response after a post-marketing data request. SHIELD-Utah study shows Novavax’s JN.1 vaccine had milder side effects than ...

WHITHER VACCINE MOOD — The World Vaccine Congress kicks off its annual conference this week in Washington, bringing together researchers, pharma executives and public health officials to discuss ...

Novavax has shared positive preliminary results from a real-world study of its JN.1-adapted COVID-19 vaccine. The SHIELD-Utah study has been comparing Novavax’s non-mRNA COVID-19 vaccine, adjuvanted ...